Related Experiment Video
Updated: Jan 11, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Post-tuberculosis lung disease: a case definition for use in research studies
Gregory P Bisson1, Brian Allwood2, Anthony Byrne3
1Department of Medicine, Division of Infectious Diseases, Perelmen School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Biostatistics, Epidemiology, and Informatics, Division of Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
A new case definition for post-tuberculosis lung disease (PTLD) aims to standardize research. This definition will improve consistency in studies on PTLD, benefiting tuberculosis survivors globally.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- Long-term pulmonary impairment is a significant issue for tuberculosis survivors.
- Variability in defining post-tuberculosis lung disease (PTLD) hinders research synthesis.
Purpose of the Study:
- To propose a standardized case definition for PTLD for research studies.
- To promote harmonization and consistency in PTLD research.
Main Methods:
- Developed through stakeholder input at the 2nd International Post-Tuberculosis Symposium.
- Refined based on guiding principles: specificity, feasibility, outcome relevance, and applicability.
- Comprises three components: prior tuberculosis, current pulmonary disease evidence, and attribution to prior tuberculosis.
Main Results:
- A proposed three-component case definition for PTLD is presented.
- A complementary reporting framework is provided.
Conclusions:
- The proposed definition aims to enhance consistency and rigor in PTLD research.
- This standardization seeks to improve the care and quality of life for tuberculosis survivors worldwide.
- The definition is intended for research use and may evolve with new evidence.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Other Pulmonary Disorders